scispace - formally typeset
Journal ArticleDOI

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

TLDR
There is a growing understanding of viral, host and environmental factors influencing disease progression, which ultimately could improve the management of chronic hepatitis B.
About
This article is published in Journal of Hepatology.The article was published on 2008-02-01. It has received 1172 citations till now. The article focuses on the topics: HBeAg & Hepatitis B.

read more

Citations
More filters
Journal ArticleDOI

EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma

TL;DR: The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
Journal ArticleDOI

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

TL;DR: This review summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States.

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

TL;DR: The purpose of this document is to assist physicians, patients, health-care providers, and health-policy makers from Europe and worldwide in the decision-making process according to evidencebased data.
Journal ArticleDOI

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

TL;DR: The objective of these EASL Clinical Practice Guidelines is to update recommendations for the optimal management of chronic hepatitis B (CHB) and the CPGs do not focus on prevention and vaccination.
Journal ArticleDOI

Hepatitis B virus infection

TL;DR: Developing new therapies that can improve HBsAg clearance and virological cure is warranted because long-term antiviral treatment can reverse cirrhosis and reduce hepatocellular carcinoma.
References
More filters
Journal ArticleDOI

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C

TL;DR: A role of the double mutation in the basic core promoter in association with genotype C and a longer duration of infection in the aggravation of chronic hepatitis B is suggested.
Journal ArticleDOI

Natural history and prognostic factors for chronic hepatitis type B.

TL;DR: Findings indicate that patients with severe chronic active hepatitis and persistent hepatitis B virus replication are at very high risk of rapid progression to cirrhosis.
Journal ArticleDOI

Natural history and prognosis of hepatitis B

TL;DR: Both cirrhotic and noncirrhotic patients with sustained reduction of HBV replication and normalization of aminotransferase after interferon alfa therapy have a reduced risk for liver-related complications.
Journal ArticleDOI

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version).

Easl Jury
TL;DR: The aim of this concert is to inspire a new generation of public speakers andators and to contribute towards the humanizing of classical music.
Journal ArticleDOI

Epidemiology and natural history of hepatocellular carcinoma.

TL;DR: In recent years, the incidence of HCC has decreased in some high-risk countries and increased in some low- Risk countries, likely related to public health efforts in Asia and the increase in hepatitis C virus infection in low- risk countries.
Related Papers (5)